This study assesses the relationship between low-density lipoprotein cholesterol levels achieved with statin treatment and cardiovascular events in patients with preexisting ischemic heart disease.
This population-based study using the Medicare Advantage database examines the differences in care between Hispanic enrollees in Puerto Rico and Hispanic and white enrollees in the United States.
This evidence summary reviews the comparative clinical effectiveness of proprotein convertase subtilisin/kexin type 9 inhibitor for the treatment of adults with familial hypercholesterolemia or cardiovascular disease and who require additional lowering of low-density lipoprotein cholesterol levels.
Ho and colleagues test a multifaceted intervention to improve cardiac medication regimen adherence and secondary prevention measures. Redberg provides an Editor’s Note.
To determine the frequency and correlates of repeat lipid testing in 35 191 VA patients with CHD who attained LDL-C goals and received no treatment intensification, Virani et al performed logistic regression analyses to evaluate facility, provider, and patient characteristics associated with repeat testing. See the Invited Commentary by Drozda and the Editor’s Note by Covinsky.